Literature DB >> 22096734

Colon cancer presenting with polymyositis-A case report.

O Rominiyi1, D M Broman, R Rajaganeshan, C R Selvasekar.   

Abstract

INTRODUCTION: Colorectal cancer most often presents with a change in bowel habit, weight loss or with bleeding per rectum. Much less commonly, colorectal cancer may present as part of a paraneoplastic syndrome. Polymyositis is a rare disease most often considered a complement-mediated idiopathic inflammatory myopathy manifested by proximal muscle weakness. However, polymyositis may also be part of a paraneoplastic syndrome associated with an underlying malignancy. The relationship between polymyositis and malignancy is well known, but it has been suggested that tumours of the large bowel are rarely complicated by myositis. PRESENTATION OF CASE: The authors describe a case report of an 82-year-old gentleman with a presumed musculoskeletal or neurological deficit who was subsequently diagnosed with metastatic colon cancer in the setting of progressive fatigue and muscle weakness. Concurrently, we review the current literature looking at the relationship between cancer and polymyositis. DISCUSSION: Colorectal cancer rarely presents with symptoms such as muscle weakness, however it is important to be aware of the possibility of an underlying malignancy when seeing patients with symptoms which are suggestive of polymyositis.
CONCLUSION: The diagnosis of polymyositis in the elderly population should raise suspicion of an underlying malignancy.

Entities:  

Keywords:  Colorectal cancer; Paraneoplastic syndrome; Polymyositis

Year:  2011        PMID: 22096734      PMCID: PMC3199706          DOI: 10.1016/j.ijscr.2011.07.004

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  10 in total

1.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

Authors:  B Sigurgeirsson; B Lindelöf; O Edhag; E Allander
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

2.  High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis.

Authors:  C R Maoz; P Langevitz; A Livneh; Z Blumstein; M Sadeh; I Bank; H Gur; M Ehrenfeld
Journal:  Semin Arthritis Rheum       Date:  1998-04       Impact factor: 5.532

Review 3.  Cancer and myositis: new insights into an old association.

Authors:  Stuart M Levine
Journal:  Curr Opin Rheumatol       Date:  2006-11       Impact factor: 5.006

4.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

5.  Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study.

Authors:  Nobuo Wakata; Teruyuki Kurihara; Eizo Saito; Masao Kinoshita
Journal:  Int J Dermatol       Date:  2002-11       Impact factor: 2.736

Review 6.  Malignancy in myositis.

Authors:  Zaki Abou Zahr; Alan N Baer
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

7.  Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.

Authors:  Yi-Ju Chen; Chun-Ying Wu; Yu-Lin Huang; Chang-Bi Wang; Jui-Lung Shen; Yun-Ting Chang
Journal:  Arthritis Res Ther       Date:  2010-04-16       Impact factor: 5.156

8.  Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark.

Authors:  W H Chow; G Gridley; L Mellemkjaer; J K McLaughlin; J H Olsen; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1995-01       Impact factor: 2.506

9.  Elevated cancer incidence in patients with dermatomyositis: a population based study.

Authors:  A Airio; E Pukkala; H Isomäki
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

Review 10.  Myositis and malignancy.

Authors:  J P Callen
Journal:  Curr Opin Rheumatol       Date:  1994-11       Impact factor: 5.006

  10 in total
  2 in total

1.  Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer.

Authors:  Aleksandra M Urbanska; Emmanouil D Karagiannis; Gonzalo Guajardo; Robert S Langer; Daniel G Anderson
Journal:  Biomaterials       Date:  2012-04-01       Impact factor: 12.479

Review 2.  Dermatomyositis and colorectal cancer: a systematic review.

Authors:  Ioannis D Gkegkes; Evelyn E Minis; Christos Iavazzo
Journal:  Ir J Med Sci       Date:  2017-11-22       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.